Drug Execs Face Capitol Hill Questions on Vaccine Supply
WASHINGTON (AP) — The top developers of U.S. COVID-19 vaccines are set to face questions from Congress about limited supplies of the shots needed to end the pandemic. The pace of vaccinations is picking up nationwide, but demand for the…


